First-Line Therapy for Metastatic Non-Small Cell Lung Cancer and an ALK Rearrangement — An Interview with Dr Justin F Gainor
Dr Justin F Gainor from Massachusetts General Hospital in Boston reviews available clinical data on ALK inhibitors and first-line treatment strategies for ALK-positive metastatic non-small cell lung cancer.
CME information and select publications here.
You May Also Like
Vida Eterna. Respuestas desde la Ciencia | Dr. Manuel Sans Segarra
Dr. Manuel Sans Segarra
Trent Loos Podcast
Trent Loos
The 365 Days of Astronomy
365DaysOfAstronomy.org
Real Ghost Stories Online
Real Ghost Stories Online | Paranormal, Supernatural & Horror Radio
Breaking Down: Collapse
Kory & Kellan
The Grave Talks | Haunted, Paranormal & Supernatural
Ghost Stores, Haunted, Paranormal & Supernatural Stories
The Biotech Startups Podcast
Excedr
The Best of Coast to Coast AM
iHeartPodcasts and Coast to Coast AM
Eye On The Sky
Vermont Public
Мослекторий
Москва 24
Vida Eterna. Respuestas desde la Ciencia | Dr. Manuel Sans Segarra
Dr. Manuel Sans Segarra
Trent Loos Podcast
Trent Loos
The 365 Days of Astronomy
365DaysOfAstronomy.org
Real Ghost Stories Online
Real Ghost Stories Online | Paranormal, Supernatural & Horror Radio
Breaking Down: Collapse
Kory & Kellan
The Grave Talks | Haunted, Paranormal & Supernatural
Ghost Stores, Haunted, Paranormal & Supernatural Stories
The Biotech Startups Podcast
Excedr
The Best of Coast to Coast AM
iHeartPodcasts and Coast to Coast AM
Eye On The Sky
Vermont Public
Мослекторий
Москва 24
Community discussion